Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Ранг среди акций #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Цена акции
$0.16328419
Рыночная капитализация
$204.14K
Изменение (1 день)
4.35%
Изменение (1 год)
102.45%
Страна
GB
Торговля Fusion Antibodies plc (FAB)

Категория

EPS для Fusion Antibodies plc (FAB)
EPS по состоянию на September 2025 TTM: $-0.02
Согласно последним финансовым отчетам и цене акций Fusion Antibodies plc, текущий EPS компании (TTM) составляет $-0.02. В конце 2024 EPS компании составлял $-0.05, меньше, чем показателю 2023 года, равному $-0.12.
История EPS компании Fusion Antibodies plc с 2013 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL